Depression and Anxiety Among Chronic Pain Patients in the Netherlands
CompletedNCT06545513
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of this study is to examine the prevalence of anxiety and depression among patients with chronic pain attending secondary and tertiary pain clinics in the Netherlands. Additionally, the study explores how pain intensity, sociodemographic factors, and the presence of anxiety or depression are associated with quality of life in this population. Using an anonymized dataset provided by the data manager, we aimed to prevent a low response rate at Amsterdam UMC and thereby reduce the risk of non-response bias.
Study details
- Official title
- The Prevalence of Depression and Anxiety Among Chronic Pain Patients in the Netherlands
- Conditions
- Chronic Pain
- Depression, Anxiety
- Sponsor
- Amsterdam UMC, location VUmc
- Start date
- 2022-08-30
- Primary completion
- 2024-11-19
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Netherlands
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Patients over 18 years old with chronic pain, who have been treated at the pain clinic at Amsterdam UMC from 2020 to 2024, will be included in the study, provided they have completed the HADS questionnaires in full. Patients with incomplete HADS questionnaires and those who have filed a general objection to the use of their data for this scientific research will be excluded from participation in the analysis.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06545513